Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study

Pharmicell

Status: Enrolling

Conditions: Alcoholic Cirrhosis

Treatments: Biological: Cellgram-LC

Study type: Interventional

Funder types: Industry

Identifiers

NCT05093881

PMC-P-07-01

Details and patient eligibility

About

This Long-term follow-up is designed to evaluate the safety of patient with Alcoholic Liver Cirrhosis who had administered Cellgram-LC in PMC-P-07 study.

Full description

To evaluate the safety for 60 months after a single dose of Cellgram-LC in patients with alcoholic liver cirrhosis.

Enrollment: 100 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Those who participated in PMC-P-07 clinical trials and received Cellgram-LC
2. Those who voluntarily agreed in writing to participate in this investigation

Exclusion criteria

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

100 participants in 1 patient group

Cellgram-LC

Experimental group

Description:

Patients with Alcoholic Liver Cirrhosis who had administered Cellgram-LC in PMC-P-07 study.

Treatment:

Biological: Cellgram-LC